Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix (BDSX) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $41000.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Amortization of Deferred Charges rose 13.89% year-over-year to $41000.0, compared with a TTM value of $147000.0 through Mar 2021, changed N/A, and an annual FY2020 reading of $144000.0, changed 0.0% over the prior year.
  • Amortization of Deferred Charges was $41000.0 for Q1 2021 at Biodesix, up from $35000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $41000.0 in Q1 2021 and bottomed at $35000.0 in Q4 2019.
  • Average Amortization of Deferred Charges over 3 years is $36750.0, with a median of $35500.0 recorded in 2019.
  • The sharpest move saw Amortization of Deferred Charges changed 0.0% in 2020, then grew 13.89% in 2021.
  • Year by year, Amortization of Deferred Charges stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then increased by 17.14% to $41000.0 in 2021.
  • Business Quant data shows Amortization of Deferred Charges for BDSX at $41000.0 in Q1 2021, $35000.0 in Q4 2020, and $36000.0 in Q1 2020.